{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dabrafenib Plus Trametinib Shows Promise in BRAFV600E-Mutated Rare Cancers

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the significance of BRAFV600 mutation.
  2. Summarize research on the efficacy and safety of dabrafenib plus trametinib combination therapy in patients with a variety of BRAFV600E-mutated cancers.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of a study examining the efficacy and safety of dabrafenib plus trametinib combination therapy in patients with a variety of BRAFV600E-mutated cancers by achieving a minimum score of 70% on the outcomes-based posttest.

Disclosures

All authors, faculty, staff, and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: OT0723
Published: July 2023
Expires: 6/5/2026
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Catlin Nalley
Categories: Advanced Practice Nursing , Cancer , Oncology
Specialties: Advanced Practice Nursing, Oncology
Topics: Cancer , Chemotherapy